As VEGFR and EGFR share common downstream signaling pathways, elevated VEGF and VEGFR expression contribute to the emergence of acquired resistance to EGFR‐TKIs in NSCLC.192. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.